BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Project Information

BQ-Technology

Grant agreement ID: 828120

DOI

10.3030/828120

Project closed

EC signature date 2 August 2018

Start date 1 August 2018

End date 30 November 2018

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

BRAINQ TECHNOLOGIES LTD
Israel

Periodic Reporting for period 1 - BQ-Technology (BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).)

Reporting period: 2018-08-01 to 2018-11-30

Summary of the context and overall objectives of the project

BrainQ is on a mission to revolutionise how we treat and manage neurological disorders such as stroke and spinal cord injury (SCI) through Artificial Intelligence (AI).
In the EU alone, the total cost of stroke to healthcare providers in 2015 was €45 Billion , with 72% of this being for direct in-hospital care based on data provided by SAFE (Stroke Alliance for Europe) . SCI, on the other hand, has lower incidence rates however still generates a substantial economic burden.
The overall onbjectives of BrainQ are related to the development and clinical validation of the innovative device, the BQ 1.0. The Phase 1 projects objectives are related to the technical and busienss feasibility assessment of the project.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

During the project, BrainQ reviewed the current stage of development and updated the development plan for the BQ 1.0. Within the duration of the project, the Company has also engaged with leading research hospitals in Italy and Spain. Discussions with these key stake holders have helped BrainQ palnning the clinical validation work foreseen in Europe.
The Company improved their understanding of the EU market and of the regulations affecting the commercialsiation of the BQ 1.0 in Europe.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The BQ 1.0 is an innovative Brain Computer Interface (BCI) - based device that provides a completely non-invasive treatment for a broad range of neurological conditions such as stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). The development of the BQ 1.0 has brought BrainQ to create a large-scale data set of EEG motor tasks currently composed of over 100,000 motor tasks files. The device delivers an electromagnetic treatment that is expected to enhance motor function and overall rehabilitation outputs for thousands of patients suffering from neuro trauma with motor impairment.

BrainQ logo